Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Valesca Retel"'
Autor:
Karen Van Der Sluis, Marieke Vollebergh, Valesca Retel, Misha Luyer, Bas Wijnhoven, Sjoerd Lagarde, Boudewijn van Etten, Richard van Hillegersberg, Wojciech Polkowski, David Hoskovec, Johanna van Sandick
Publikováno v:
European Journal of Surgical Oncology. 49:e40
Autor:
Zakile A. Mfumbilwa, Janneke A. Wilschut, Martijn J.H.G. Simons, Bram Ramaekers, Manuela Joore, Valesca Retel, Christine M. Cramer-van der Welle, Franz M.N.H. Schramel, Ewoudt M.W. van de Garde, Veerle M.H. Coupé
Recent discoveries in molecular diagnostics and lung cancer drugs have improved the treatment of patients with advanced (inoperable) non-squamous NSCLC from solely platinum based chemotherapy to more personalized treatment including targeted therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3e2f11cf1cad226846dcc1121fec9d5
https://doi.org/10.21203/rs.3.rs-1275947/v1
https://doi.org/10.21203/rs.3.rs-1275947/v1
Autor:
Zakile A Mfumbilwa, Janneke A Wilschut, Martijn J.H.G Simons, Bram Ramaekers, Manuela Joore, Valesca Retel, Christine M Cramer-van der Welle, Franz M.N.H Schramel, Ewoudt M.W van de Garde, Veerle M.H Coupé
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S56-S56
IntroductionPatients treated with immunotherapy are divided into two subgroups: (i) long-term survivors (LTS) and (ii) moderate survivors. Nevertheless, clinical trials (RCTs) report only average treatment effects such as hazard rate (HRs). Health ec
Autor:
Alessandra I. G. Buma, Berber Piet, Rob ter Heine, Michel M. van den Heuvel, Paul Brinkman, Daan van den Broek, Sjaak Burgers, Francesco Ciompi, Simona M. Cristescu, Bram van Ginneken, Katrien Grünberg, Lizza Hendriks, Jeroen Hiltermann, Firdaus Mohamed Housein, Alwin Huitema, Jakko van Inge, Colin Jacobs, Hans Koenen, Marjolijn Ligtenberg, Anke H. Maitland-van der Zee, Vincent van der Noort, Mathias Prokop, Valesca Rètel, Heinrich Roder, Huub van Rossum, Ruben Smeets, Thomas Würdinger
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Personalization of treatment offers the opportunity to treat patients more effectively based on their dominant disease-specific features. The increasing number and types of treatment, and the high costs associated with these treatments, however, dema
Externí odkaz:
https://doaj.org/article/625220bc2e1044659b79873cb9c7aed9
Autor:
Zakile A. Mfumbilwa, Janneke A. Wilschut, Martijn J. H. G. Simons, Bram Ramaekers, Manuela Joore, Valesca Retèl, Christine M. Cramer-van der Welle, Franz M. N. H. Schramel, Ewoudt M. W. van de Garde, Veerle M. H. Coupé
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Recent discoveries in molecular diagnostics and drug treatments have improved the treatment of patients with advanced (inoperable) non-squamous non-small cell lung cancer (NSCLC) from solely platinum-based chemotherapy to more personalized t
Externí odkaz:
https://doaj.org/article/fa5c1807869049718099709fd7398401
Autor:
Melanie Lindenberg, Astrid Kramer, Esther Kok, Valesca Retèl, Geerard Beets, Theo Ruers, Wim van Harten
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background A first pilot study showed that an image-guided navigation system could improve resection margin rates in locally advanced (LARC) and locally recurrent rectal cancer (LRRC) patients. Incremental surgical innovation is often implem
Externí odkaz:
https://doaj.org/article/50ea3435def14a839efa54da2b0bbd9c
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background This study shows how dynamic simulation modeling can be applied in the context of the nationwide implementation of Whole Genome Sequencing (WGS) for non-small cell lung cancer (NSCLC) to inform organizational decisions regarding t
Externí odkaz:
https://doaj.org/article/7a85232c28ff4b8eb54957899b030b87
Autor:
Amber D. Zegers, Pieter Coenen, Ute Bültmann, Valesca Retèl, Jacobien M. Kieffer, Allard J. van der Beek, Saskia F. A. Duijts
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-20 (2021)
Abstract Background Many cancer survivors experience physical and/or psychosocial problems affecting return to work (RTW) and work retention. Current interventions on RTW lack evidence regarding effectiveness, while interventions for work retention a
Externí odkaz:
https://doaj.org/article/ee04e6b395764b48a8938132faaf3d1e
Autor:
Melanie Lindenberg, Valesca Retèl, Maartje Rohaan, Joost van den Berg, John Haanen, Wim van Harten
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Treatment with tumor-Infiltrating Lymphocytes (TIL) is an innovative therapy for advanced melanoma with promising clinical phase I/II study results and likely beneficial cost-effectiveness. As a randomized controlled trial on the
Externí odkaz:
https://doaj.org/article/eccf11d55d204d1c83c7c9d76456d1ed
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232690 (2020)
INTRODUCTION:Current localization techniques used in breast conserving surgery for non-palpable tumors show several disadvantages. Magnetic Seed Localization (MSL) is an innovative localization technique aiming to overcome these disadvantages. This s
Externí odkaz:
https://doaj.org/article/d6c5cf2d463741da95f48f917fabb21e